(Q34426624)

2 August 2017

1 reference

title

Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease (English)

1 reference

2 August 2017

0 references

Rui Wang

1

1 reference

2 August 2017

Xi Can Tang

series ordinal

2

1 reference

2 August 2017

publication date

1 January 2005

1 reference

2 August 2017

1 reference

2 August 2017

volume

14

1 reference

2 August 2017

issue

1-2

1 reference

2 August 2017

page(s)

71-82

1 reference

Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach

2 August 2017

cites work

1 reference

A synaptic model of memory: long-term potentiation in the hippocampus

21 January 2018

1 reference

Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization.

21 January 2018

1 reference

Molecular forms of acetylcholinesterase in brain, nerve and muscle: Nature, localization and dynamics

21 January 2018

1 reference

Elevated oxidative stress in models of normal brain aging and Alzheimer's disease

21 January 2018

1 reference

Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides

21 January 2018

1 reference

Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities

21 January 2018

1 reference

Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage

21 January 2018

1 reference

Calcium: still center-stage in hypoxic-ischemic neuronal death

21 January 2018

1 reference

Excitotoxic injury of the neostriatum: a model for Huntington's disease

21 January 2018

1 reference

Pathobiology of ischaemic stroke: an integrated view

21 January 2018

1 reference

Antioxidant Treatment in Alzheimer's Disease: Current State

21 January 2018

1 reference

The NMDA receptor ion channel: a site for binding of Huperzine A.

21 January 2018

1 reference

Programmed cell death in cerebral ischemia

21 January 2018

1 reference

Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide

21 January 2018

1 reference

The permeability transition pore complex: another view.

21 January 2018

1 reference

Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

Mitochondrial permeability transition: a common pathway to necrosis and apoptosis

21 January 2018

1 reference

Increased apoptotic cell death in sporadic and genetic Alzheimer's disease

21 January 2018

1 reference

The changing landscape of ischaemic brain injury mechanisms.

21 January 2018

1 reference

Huperzine A inhibits the sustained potassium current in rat dissociated hippocampal neurons

21 January 2018

1 reference

Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats

21 January 2018

1 reference

Excitatory amino acids as a final common pathway for neurologic disorders.

21 January 2018

1 reference

Oxidative stress hypothesis in Alzheimer's disease

21 January 2018

1 reference

Effect of huperzine A on working memory in reserpine- or yohimbine-treated monkeys

21 January 2018

1 reference

Rationalizing a pharmacological intervention on the amyloid precursor protein metabolism.

21 January 2018

1 reference

The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling

21 January 2018

1 reference

Evidence for apoptotic cell death in Alzheimer's disease.

21 January 2018

1 reference

NMDA receptors: from genes to channels

21 January 2018

1 reference

Apoptosis driven by IP(3)-linked mitochondrial calcium signals

21 January 2018

1 reference

Huperzine A: A novel acetylcholinesterase inhibitor

21 January 2018

1 reference

ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma

21 January 2018

1 reference

Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats.

21 January 2018

1 reference

Huperzine A attenuates cognitive deficits and brain injury in neonatal rats after hypoxia-ischemia

21 January 2018

1 reference

Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein-(1-40) in rat.

21 January 2018

1 reference

Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine

21 January 2018

1 reference

Effect of huperzine A, a novel acetylcholinesterase inhibitor, on radial maze performance in rats

21 January 2018

1 reference

Enhancement of outward potassium current may participate in beta-amyloid peptide-induced cortical neuronal death

21 January 2018

1 reference

Apoptosis in the nervous system

21 January 2018

1 reference

The mitochondrion in apoptosis: how Pandora's box opens

21 January 2018

1 reference

Stereoselectivities of enantiomers of huperzine A in protection against beta-amyloid(25-35)-induced injury in PC12 and NG108-15 cells and cholinesterase inhibition in mice

21 January 2018

1 reference

Huperzine A attenuates the neurotoxic effect of staurosporine in primary rat cortical neurons

21 January 2018

1 reference

Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-alpha in intracerebroventricular beta-amyloid-(1-40) infused rats and human embryonic kidney 293 Swedish mutant cells

21 January 2018

1 reference

Huperzine A, a nootropic alkaloid, inhibits N-methyl-D-aspartate-induced current in rat dissociated hippocampal neurons

21 January 2018

1 reference

Spermidine antagonizes the inhibitory effect of huperzine A on [3H]dizocilpine (MK-801) binding in synaptic membrane of rat cerebral cortex

21 January 2018

1 reference

Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine

21 January 2018

1 reference

Huperzine A protects rat pheochromocytoma cells against oxygen-glucose deprivation

21 January 2018

1 reference

Huperzine A and donepezil protect rat pheochromocytoma cells against oxygen-glucose deprivation

21 January 2018

1 reference

Huperzine A attenuates cognitive deficits and hippocampal neuronal damage after transient global ischemia in gerbils

21 January 2018

1 reference

Huperzine A attenuates apoptosis and mitochondria-dependent caspase-3 in rat cortical neurons

21 January 2018

1 reference

Protective effects of huperzine A on β-amyloid25–35 induced oxidative injury in rat pheochromocytoma cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000085387

1 reference

2 August 2017

1 reference